CLU and Cognitive impairment: The meta-analysis by Yang et al. (2018) agreed with this evidence, showing that a high concentration of CLU in the plasma and brain is associated with dementia, especially in AD [80], proposing this protein as a biomarker of cognitive impairment severity [81].